COMPANY
Clinical Phase 1
Keywords: immuno-oncology Triple Negative Breast Cancer Colorectal Cancer Hepatocellular Carcinoma Osteosarcoma Epithelial Ovarian Cancer Gastric Cancer Non-small Cell Lung Cancer Malignant Melanoma CRX100
Location: Mountain View, CA · source · Oct 12, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 1: Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT04282044 | Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies | Phase 1 | Recruiting | Jan 8, 2021 | 2025-08 (estimated) |
